Aptevo Therapeutics
APVO
APVO
12 hedge funds and large institutions have $107M invested in Aptevo Therapeutics in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
12
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$64.5M | |
| 2 | +$10.6M | |
| 3 | +$3.31M | |
| 4 |
Two Sigma Investments
New York
|
+$2.56M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.83M |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$1.14M | |
| 3 | -$412K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$344K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$308K |